Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
QICClass II

Hiv-1 Genotyping Assay Using Ngs Technology

21 CFR 866.3955 / Medical Genetics

QIC is the FDA product code for Hiv-1 Genotyping Assay Using Ngs Technology, a class II device type, regulated under 21 CFR 866.3955. FDA's definition for this code reads: "The human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing (NGS) technology is a prescription in vitro diagnostic device intended for use in detecting HIV genomic mutations that confer resistance to specific anti-retroviral drugs. The device is intended to be used as an...". As of , FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code
QIC
Device name
Hiv-1 Genotyping Assay Using Ngs Technology
FDA definition
The human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing (NGS) technology is a prescription in vitro diagnostic device intended for use in detecting HIV genomic mutations that confer resistance to specific anti-retroviral drugs. The device is intended to be used as an aid in monitoring and treating HIV infection.
Regulation
21 CFR 866.3955
Device class
Class II
Review panel
Medical Genetics
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
0
Ingested recalls
0

Companies listing this code with FDA

Companies whose registered establishments list this code